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Abstract
Chronic and recurrent bone infections occur frequently but 
have not been explained. Staphylococcus aureus (S. aureus) 
is often found among chronic and recurrent infections and 
may be responsible for such infections. One possible reason 
is that S. aureus can internalize and survive within host cells 
and by doing so, S. aureus can evade both host defense 
mechanisms and most conventional antibiotic treatments. 
In this study, we hypothesized that intra-cellular S. aureus 
could induce infections in vivo. Osteoblasts were infected 
with S. aureus and, after eliminating extra-cellular S. aureus, 
inoculated into an open fracture rat model. Bacterial cultures 
and radiographic observations at post-operative day 21 
confirmed local bone infections in animals inoculated with 
intra-cellular S. aureus within osteoblasts alone. We present 
direct in vivo evidence that intra-cellular S. aureus could 
be sufficient to induce bone infection in animals; we found 
that intra-cellular S. aureus inoculation of as low as 102 
colony forming units could induce severe bone infections. 
Our data may suggest that intra-cellular S. aureus can 
“hide” in host cells during symptom-free periods and, under 
certain conditions, they may escape and lead to infection 
recurrence. Intra-cellular S. aureus therefore could play an 
important role in the pathogenesis of S. aureus infections, 
especially those chronic and recurrent infections in which 
disease episodes may be separated by weeks, months, or 
even years.
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cellular pathogen; Staphylococcus aureus; in vivo.
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Introduction
Bone infection or osteomyelitis is a significant clinical 
problem that can lead to prolonged hospitalization, sepsis, 
poor functional outcome, and even death (Sugarman and 
Young, 1989; Johnson et al., 2007; de Lissovoy et al., 
2009; Pull ter Gunne and Cohen, 2009). Patients with 
traumatic open fractures have a high risk of infection 
(5-33 %) due to microbial contamination and soft tissue 
damage (Zalavras and Patzakis, 2003); such infections are 
often hard to eradicate, chronic, and recurrent (Berendt 
and Byren, 2004). For instance, over a million Americans 
are hospitalized every year for bone fractures (Canale, 
2003); such injuries are increasingly common because of 
increased survivability of high energy trauma in civilian 
settings as well as in combat activities. Treatment of bone 
infections, particularly chronic and recurrent infections, 
frequently requires long-term hospitalization for repeated 
debridements and prolonged parenteral antibiotic therapy. 
Bacteria including Staphylococcus aureus (S. aureus), 
however, are often surprisingly successful in overcoming 
both host defense mechanisms and antibiotic treatments 
and result in chronic and recurrent bone infections. Indeed, 
a high rate of recurrence of bone infections was reported 
where ~17 % of infections related to traumatic extremity 
injuries recur (Murray et al., 2008; Murray et al., 2011). 
One approach that bacteria may use to elude host defenses 
and antibiotics is to “hide” themselves intra-cellularly 
within host cells (Ciampolini and Harding, 2000).
 A wide range of bacterial species related to bone 
infections has been isolated. The pathogen S. aureus is one 
of the most common causative agents of bone infections 
(Sax and Lew, 1999). S. aureus commonly colonizes the 
skin, skin glands, and mucous membranes, specifically 
in the noses of healthy individuals. S. aureus expresses 
a large number of cell surface proteins (i.e. adhesins) of 
the microbial surface components that recognize adhesive 
matrix molecules or MSCRAMMs (Patti and Höök, 1994; 
Clarke and Foster, 2006) by which it can colonize the 
bone matrix and adhere to bone cell surfaces. S. aureus, 
while generally considered an extra-cellular pathogen, 
is one such bacterium that has the ability to invade and 
live within different cell types, both phagocytic and non-
phagoytic cells (reviewed by Garzoni and Kelley, 2009). 
By “hiding” inside the host cells, S. aureus may elude 
host defenses and most antibiotic treatments, and may be 
responsible for chronic and recurrent bone infections.
 The objective of this study was to determine whether 
intra-cellular S. aureus can induce bone infections in a 
rat model. By pre-infecting osteoblasts in vitro with S. 
INTRA-CELLULAR STAPHYLOCOCCUS AUREUS ALONE CAUSES
INFECTION IN VIVO
Therwa Hamza1,2, Matthew Dietz1, Danh Pham1, Nina Clovis1, Suzanne Danley1 and Bingyun Li1,2,3,4,*
1Department of Orthopaedics, School of Medicine, West Virginia University, Morgantown, WV 26506, USA
2Department of Basic Pharmaceutical Sciences, School of Pharmacy, West Virginia University, Morgantown,
WV 26506, USA
3WVNano Initiative, Morgantown, WV 26506, USA
4Mary Babb Randolph Cancer Center, Morgantown, WV 26506, USA
342 www.ecmjournal.org
T Hamza et al.                                                                                        Intra-cellular S. aureus causes infection in vivo
aureus, killing extra-cellular bacteria with gentamicin, 
and inoculating infected osteoblasts into an open fracture 
rat model, we examined bone infections in rats induced by 
intra-cellular S. aureus.
Materials and Methods
Reagents
Dulbecco’s modified Eagle’s medium/F-12 (DMEM/F-12) 
and phosphate buffered saline (PBS) were purchased from 
Lonza (Walkersville, MD, USA). Tryptic soy broth (TSB) 
and tryptic soy agar (TSA w/5 % sheep blood) were from 
Fisher Scientific (Pittsburgh, PA, USA). Fetal bovine 
serum (FBS), 0.25 % trypsin-ethylenediaminetetraacetic 
acid (EDTA), and a solution of penicillin (100 U/mL)/
streptomycin (100 mg/mL) were obtained from Invitrogen 
(Carlsbad, CA, USA). Triton X-100 was from Sigma-
Aldrich (St. Louis, MO, USA). S. aureus (ATCC 25923) 
and rat osteoblast cells (UMR-106) were purchased from 
American Type Culture Collection (ATCC, Manassas, 
VA, USA). Susceptibility tests showed that the S. aureus 
strain was susceptible to cefazolin, cefoxitin, ciprofloxacin, 
clindamycin, erythromycin, gentamicin, levofloxacin, 
linezolid, moxifloxacin, oxacillin, penicillin, rifampin, 
tetracycline, tigecycline, and vancomycin and was resistant 
to ampicillin.
Preparation of osteoblasts with intra-cellular S. 
aureus
Rat osteoblast cells were seeded at a density of 5×105 
osteoblasts/mL and cultured in 6-well plates overnight 
in DMEM/F-12 supplemented with 10 % FBS and 1 % 
penicillin/streptomycin solution to form a monolayer. Fresh 
S. aureus inoculum was prepared by suspending 5 colonies 
of S. aureus into 5 mL TSB and incubating at 37 °C for 
18 h. The bacterial suspension was centrifuged (3,750 rpm) 
at 4 °C for 15 min and washed once with PBS; its optical 
density was adjusted to 5×108 colony forming units/mL 
(CFU/mL) of S. aureus. Rat osteoblasts and S. aureus 
were then cultured as follows (Fig. 1A): (i) The osteoblast 
monolayer was washed twice with PBS. S. aureus was 
pelleted, re-suspended in DMEM/F-12 (without FBS and 
antibiotics), and then added to the osteoblast monolayer 
at a multiplicity of infection (MOI) of 500:1 (S. aureus to 
osteoblasts). Osteoblasts and S. aureus were next cultured 
together at 37 °C in a 5 % CO2 humidified incubator for 
2 h. (ii) The osteoblast monolayer was washed twice with 
PBS to remove any non-adherent bacteria, and cell culture 
media supplemented with gentamicin (100 μg/mL) was 
added and kept for 2 h to kill any extra-cellular bacteria. 
Gentamicin treatment is commonly used to eliminate 
extra-cellular bacteria (Wright and Friedland, 2002; 
Jevon, et al., 1999); gentamicin is unable to penetrate 
mammalian cell membranes within short time periods 
(Plotkowski et al., 1999; Hamad et al., 2010). After 
gentamicin treatment, osteoblasts were detached and viable 
osteoblasts were counted using a hemocytometer (Bright-
Line Hausser Scientific, Horsham, PA, USA) following the 
trypan-blue exclusion assay; the viability of osteoblasts 
was approximately 94.2 ±5.5 %. Infected osteoblasts 
were immediately used; intra-cellular S. aureus within 
osteoblasts prior to inoculation into rats was imaged (Fig. 
1B). (iii) Samples of infected osteoblasts were lysed using 
Triton X-100. (iv) Cell lysates were cultured on blood agar 
plates to determine the CFU that represented the viable 
colonies of intra-cellular S. aureus within osteoblasts. To 
examine the viability of infected osteoblasts at days post-
infection, non-infected (control) and infected osteoblasts 
were cultured in DMEM/F12 supplemented with 5 % FBS 
Fig. 1. (A) A schematic diagram of the infection model of 
osteoblasts and S. aureus: (i) Rat osteoblasts were infected 
with S. aureus for 2 h. (ii) Extra-cellular S. aureus were 
killed with gentamicin. (iii) Osteoblasts were lysed using a 
lysing buffer. (iv) Cell lysates were cultured on blood agar 
plates to count live intra-cellular S. aureus colonies. (B) 
TEM imaging of intra-cellular S. aureus within osteoblasts.(A)
(B)
343 www.ecmjournal.org
T Hamza et al.                                                                                        Intra-cellular S. aureus causes infection in vivo
and 5 μg/mL lysostaphin solution for 1 and 7 d; media was 
changed every 3 d for the day 7 samples. Lysostaphin does 
not penetrate mammalian cell membranes for long time 
periods, e.g. weeks (Easmon et al., 1978; Kumar, 2008; 
Maurin and Raoult, 2001). The viability of osteoblasts at 
post-infection days 1 and 7 was calculated relevant to their 
control (non-infected) cells. The viability of the infected 
osteoblasts was found to be 84.6 ±6.7 % and 77.4 ±0.6 % 
at post-infection days 1 and 7, respectively.
Animal groups and open fracture infection procedure
The study was approved by the West Virginia University 
Institutional Animal Care and Use Committee. Male 
Sprague-Dawley rats (400-450 g) were obtained from 
Hilltop Lab Animals (Scottdale, PA). Our open femur 
fracture rat model (Li et al., 2009; Boyce et al., 2012) 
was modified and the surgical procedure is described in 
brief as follows (Fig. 2): After sedation of the animals 
with intraperitoneal anesthetic, one hind leg was shaved 
prior to fracture. A midshaft femur fracture was produced 
using a custom-made device (Fig. 2A), the surgical site 
was disinfected, an incision was made to expose the 
fracture (Fig. 2B), and then the fracture was fixed using 
an intramedullary stainless steel Kirschner wire or K-wire 
(Fig. 2C). Next, 100 μL of treatment solution was gently 
pipetted into the fracture site without contacting the surgical 
instruments (Fig. 2D). Based on the treatment solutions, 
rats were randomly assigned to one of the following six 
groups (six rats per group) (Table 1). The incision was 
carefully closed (Fig. 2E) and post-operative radiographs 
were taken to verify fracture fixation. All animals were 
monitored for the study duration of 3 weeks and euthanized 
at post-operative day 21. Note that both 102 and 106 CFU 
of extra-cellular S. aureus induced bone infections in the 
same open fracture rat model (Li et al., 2009; Li et al., 
2010; Boyce et al., 2012), and a lower extra-cellular S. 
aureus dose of 20 CFU, which was expected not to induce 
infection, was chosen here to evaluate the potential role 
of intra-cellular S. aureus by comparing Group III with 
Group VI.
Microbiological and radiographic evaluations
At euthanasia, bone and muscle tissue were collected in 
15 mL centrifuge tubes with 5 mL PBS and homogenized. 
Samples of bone and muscle homogenates were diluted 
and plated on blood agar plates and S. aureus colonies 
were counted after incubating the plates at 37 °C for 
24 h. In addition, K-wires used to fix the fractured femurs 
were collected at euthanasia, cut into 2 cm-long pieces, 
rolled on blood agar plates, and cultured at 37 °C for 24 h. 
Radiographs were taken at post-operative days 0, 7 and 21.
Body weight and complete blood count
The body weights of the animals were taken on the day of 
surgery and immediately before euthanasia; the net weight 
Fig. 2. Surgical procedures: The rat’s femur was fractured, fixed with a K-wire, and inoculated with 0.1 mL solution of 
the assigned inoculum. (A) Creation of a femur fracture using a custom-designed setup. (B) Exposure of the fracture. 
(C) Intramedullary fixation of the fracture using a K-wire. (D) Inoculation of 0.1 mL solution using a pipette. (E) 
Closure of incision.
Table 1. Animal groups for open fracture infection 
procedure.
*This solution was obtained by diluting the 106 CFU of 
intra-cellular S. aureus (i.e. Group V) with non-infected 
osteoblasts.
Group Treatment solution (100 µL)
Group I PBS
Group II 106 osteoblasts
Group III
106 osteoblasts combined with 20 CFU of extra-
cellular S. aureus
Group IV*
106 osteoblasts with 102 CFU intra-cellular S. 
aureus
Group V
106 osteoblasts infected with 106 CFU intra-
cellular S. aureus
Group VI
106 osteoblasts infected with 106 CFU intra-
cellular S. aureus combined with 20 CFU of 
extra-cellular S. aureus
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gain/loss was calculated. Blood samples were collected 
from the heart immediately prior to euthanasia and 
analyzed for complete blood counts by Antech Diagnostics, 
Inc. (Southaven, MS, USA).
Statistical analysis
Values of CFU, body weight gain/loss, and blood cell 
counts were expressed as mean ± standard deviation. 
Differences in body weight gain/loss and blood cell counts 
were analyzed using one-way ANOVA. p value < 0.05 was 
considered statistically significant. JMP (V9) software was 
used (SAS Institute, Inc., Cary, NC, USA).
Results
Intra-cellular S. aureus causes high bacterial burden 
in bone and muscle tissue
Rats (Groups IV, V, and VI) inoculated with infected 
osteoblasts (102 or 106 CFU of intra-cellular S. aureus) led 
to high CFU counts (i.e. ~106 CFU/mL) at post-operative 
day 21 in the bone and muscle samples (Fig. 3A). There 
were no significant differences in CFU among the groups 
(i.e. Groups IV, V, and VI) inoculated with infected 
osteoblasts at post-operative day 21, although relatively 
higher CFU counts were found in the bone samples 
compared to the muscle samples of the same group. By 
contrast, no bacteria were observed at post-operative day 
21 in the rats (i.e. Groups I, II, and III) inoculated with 
PBS, osteoblasts, and osteoblasts combined with 20 CFU 
of extra-cellular S. aureus (Fig. 3A). Correspondingly, 
heavy bacterial growth was seen in the blood agar plates 
rolled with the K-wires from animals inoculated with 
infected osteoblasts (102 or 106 CFU), while no bacterial 
colonies were found in K-wires extracted from animals 
inoculated with PBS, osteoblasts, and osteoblasts combined 
with 20 CFU of extra-cellular S. aureus (Fig. 3B). Gross 
observation before euthanasia showed clear pus pockets at 
the fracture sites in rats inoculated with infected osteoblasts 
(i.e. Groups IV, V, and VI). No S. aureus growths (data not 
(A)
(B)
Fig. 3. (A) Bone (femur) and muscle tissue homogenates reported high S. aureus CFUs in the animal groups inoculated 
with infected osteoblasts (i.e. Groups IV, V, and VI); six rats in each group. No CFUs were found in the groups 
inoculated with PBS, osteoblasts, and a mixture of osteoblasts and 20 CFUs of extra-cellular S. aureus (i.e. Groups 
I, II, and III). (B) K-wire rolling experiments showed high S. aureus growth in the groups inoculated with infected 
osteoblasts; no bacterial growth was observed in the groups inoculated with PBS, osteoblasts, and a mixture of 
osteoblasts and extra-cellular S. aureus (20 CFU). Group I: PBS; Group II: 106 osteoblasts; Group III: 106 osteoblasts 
combined with 20 CFU of extra-cellular S. aureus; Group IV: 106 osteoblasts with 102 CFU intra-cellular S. aureus; 
Group V: 106 osteoblasts infected with 106 CFU intra-cellular S. aureus; Group VI: 106 osteoblasts infected with 106 
CFU intra-cellular S. aureus combined with 20 CFU of extra-cellular S. aureus.
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Fig. 4. (A) Radiographs of fractured femurs at post-operative day 21 presented significant osteolysis in the animal 
groups inoculated with infected osteoblasts (i.e. Groups IV, V, and VI), while normal bone healing was seen in the 
groups inoculated with PBS, osteoblasts, and a mixture of osteoblasts and extra-cellular S. aureus (20 CFU) (i.e. 
Groups I, II, and III). (B) Radiographs of fractured femurs at post-operative day 0, 7 and 21 did not show severe 
osteolysis in the rats inoculated with infected osteoblasts (e.g. Group VI) at post-operative day 7. The dashed circles 
indicate the areas of significant osteolysis. The curled wires were the stainless steel sutures used to close the incision. 
Group I: PBS; Group II: 106 osteoblasts; Group III: 106 osteoblasts combined with 20 CFU of extra-cellular S. aureus; 
Group IV: 106 osteoblasts with 102 CFU intra-cellular S. aureus; Group V: 106 osteoblasts infected with 106 CFU 
intra-cellular S. aureus; Group VI: 106 osteoblasts infected with 106 CFU intra-cellular S. aureus combined with 20 
CFU of extra-cellular S. aureus.
(A)
(B)
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shown) were observed at post-operative day 21 in any of 
the blood samples.
Radiographic assessment of bone infection
No signs of infection were observed at post-operative 
day 21 in the radiographs of rats (i.e. Groups I, II, and 
III) inoculated with PBS, osteoblasts, and osteoblasts 
combined with 20 CFU of extra-cellular S. aureus (Fig. 
4A). The radiographic images of these animals were 
characterized by the formation of normal bridging calluses 
at the fracture sites. By contrast, groups (i.e. Groups IV, 
V, and VI) inoculated with infected osteoblasts (102 or 106 
CFU) showed severe osteolysis at post-operative day 21. 
Meanwhile, no severe osteolysis was observed at post-
operative day 7 in the animals inoculated with infected 
osteoblasts (Fig. 4B); this may indicate that it takes time 
(more than 7 d) to develop infection in this animal model.
Fig. 5. Net weight loss of the rats at post-operative day 21 was significantly higher in the animal groups inoculated 
with infected osteoblasts (i.e. Groups V and VI) compared to those in the groups inoculated with PBS, osteoblasts, 
and a mixture of osteoblasts and 20 CFU of extra-cellular S. aureus (i.e. Groups I, II, and III). Data were an average 
of six rats in each group. Error bars were standard deviations. Group I:  PBS; Group II: 106 osteoblasts; Group III: 
106 osteoblasts combined with 20 CFU of extra-cellular S. aureus; Group IV: 106 osteoblasts with 102 CFU intra-
cellular S. aureus; Group V: 106 osteoblasts infected with 106 CFU intra-cellular S. aureus; Group VI: 106 osteoblasts 
infected with 106 CFU intra-cellular S. aureus combined with 20 CFU of extra-cellular S. aureus.
Fig. 6. Complete blood counts at post-operative day 21 showed that neutrophil numbers were significantly higher in 
the animal groups inoculated with infected osteoblasts (i.e. Groups IV, V, and VI) compared to those groups inocu-
lated with osteoblasts and a mixture of osteoblasts and 20 CFU of extra-cellular S. aureus (i.e. Groups II and III). 
Error bars were standard deviations. Group I: PBS; Group II: 106 osteoblasts; Group III: 106 osteoblasts combined 
with 20 CFU of extra-cellular S. aureus; Group IV: 106 osteoblasts with 102 CFU intra-cellular S. aureus; Group 
V: 106 osteoblasts infected with 106 CFU intra-cellular S. aureus; Group VI: 106 osteoblasts infected with 106 CFU 
intra-cellular S. aureus combined with 20 CFU of extra-cellular S. aureus.
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Body weight and complete blood counts
A significant loss in body weight was observed in rat groups 
(i.e. Groups V and VI) inoculated with infected osteoblasts 
of 106 CFU of intra-cellular S. aureus and 106 CFU of intra-
cellular S. aureus combined with 20 CFU of extra-cellular 
S. aureus compared to the groups (i.e. Groups I, II, and III) 
inoculated with PBS, osteoblasts, and osteoblasts combined 
with 20 CFU of extra-cellular S. aureus (Fig. 5). More 
weight loss was also observed in Group IV inoculated with 
infected osteoblasts of 102 CFU of intra-cellular S. aureus 
compared to Groups I, II, and III; however, the differences 
were not statistically significant (Fig. 5).
 The neutrophils in the blood of groups (i.e. Groups IV, 
V, and VI) inoculated with infected osteoblasts (102 or 106 
CFU) were significantly elevated at post-operative day 21 
compared to the groups (i.e. Groups II and III) inoculated 
with osteoblasts and osteoblasts combined with 20 CFU of 
extra-cellular S. aureus (Fig. 6). No significant differences 
(data not shown) were seen at post-operative day 21 in 
the numbers of lymphocytes, monocytes, and eosinophils 
among all the groups studied.
Discussion
S. aureus is a human pathogen causing significant 
morbidity and mortality in both community- and hospital-
acquired infections. Surprisingly, S. aureus frequently 
overcomes both host defense mechanisms and most 
antibiotic treatments. It is often found in chronic and 
recurrent infections and could be responsible for such 
infections. This bacterium is believed to have developed 
several means to combat conventional antibiotic therapies, 
among which are its ability to survive for long periods of 
time inside host cells (Garzoni and Kelley, 2009). The 
purpose of the present study was to examine whether intra-
cellular S. aureus contributes to infection in vivo. Efforts 
were implemented to completely eradicate extra-cellular S. 
aureus in the inoculums by treating them with gentamicin; 
the complete killing of extra-cellular S. aureus was proved 
in our studies as well as in studies by others (Plotkowski 
et al., 1999; Hamrick et al., 2003; Hamad et al., 2010; 
Hamza and Li, 2012). Also, gentamicin remaining in the 
inoculums was expected to eliminate any extra-cellular S. 
aureus that leaked out within the first few hours.
 We investigated whether intra-cellular S. aureus within 
osteoblasts could induce infection in our open femur 
fracture rat model. Note that this model is not an animal 
model of recurrent infection. This model was chosen 
because open fractures have high rates of infection and 
infection recurrence; a high rate of recurrent infections 
was reported in traumatic extremity injuries (Murray et 
al., 2008; Murray et al., 2011). We found that animals 
inoculated with S. aureus infected osteoblasts with intra-
cellular S. aureus CFU of 102 (i.e. Group IV) and 106 
(i.e. Group V) all led to severe infections, confirmed by 
culturing bone and muscle tissue from the infection sites 
and explanted K-wires (Fig. 3) and radiographic analysis of 
the fracture (Fig. 4). Inoculation of intra-cellular S. aureus 
alone of 102 CFU led to the same degree of infection as 106 
CFU inoculum, evidenced by approximately the same CFU 
in bone and muscle tissue at post-operative day 21 (Fig. 
3). Animals inoculated with no bacteria (i.e. Groups I and 
II) or with 20 CFU of extra-cellular S. aureus (i.e. Group 
III) did not have evidence of infection at post-operative 
day 21. No systemic infection was observed in any of the 
groups investigated because no CFU was found in blood 
samples. These results suggest that intra-cellular S. aureus 
inoculum of as low as 102 CFU within osteoblasts induced 
bone infections in our rat open femur fracture model and 
that the infection was localized.
 It was interesting that severe bone infections were 
induced by intra-cellular S. aureus within osteoblasts at 
102 CFU, which was the same quantity of inoculum as 
our previous rat studies where 102 CFU of extra-cellular 
S. aureus was sufficient to induce bone infections in our 
open fracture rat model (Li et al., 2009; Li et al., 2010; 
Boyce et al., 2012). This suggested that not only extra-
cellular but also intra-cellular S. aureus alone at 102 CFU 
could induce severe bone infections in open fractures. Note 
that inoculation of uninfected osteoblasts did not cause 
infection; no CFU was observed in corresponding bone, 
muscle, or K-wire samples (Fig. 3).
 Meanwhile, neutrophils were significantly increased 
at post-operative day 21 in the groups inoculated with 
infected osteoblasts. This might suggest that neutrophils 
have played a deleterious role in infections induced by S. 
aureus infected osteoblasts. In the literature, neutrophils 
may have a protective or a deleterious role in S. aureus 
infection. On the one hand, neutrophils have long been 
believed to provide significant host defense against S. 
aureus infection. This is mainly because patients who are 
neutropenic or who have defects in neutrophil functions 
are more susceptible to S. aureus infection; total ablation 
of neutrophils in an experimental mouse model of S. 
aureus-induced septic arthritis led to decreased survival 
of the animals and increased bacteremia (Verdrengh and 
Tarkowski, 1997). On the other hand, increased neutrophils 
were also found to correlate with decreased survival of 
mice and increased bacterial burden at the infection site 
(Lowrance et al., 1994; Caver et al., 1996).
 It is important to note that both in vitro and in vivo 
studies have shown that bacteria like S. aureus and S. 
epidermidis can internalize and survive within both 
phagocytic and non-phagocytic cells. In vitro, S. aureus can 
invade and survive within polymorphonuclear neutrophils 
and monocytes (Rogers and Tompsett, 1952; Kapral and 
Shayegani, 1959; Melly et al., 1960), endothelial cells 
(Vriesema et al., 2000), and osteoblasts (Hudson et al., 
1995; Jevon et al., 1999; Ellington et al., 2003). Infected 
human osteoblasts were shown to release viable S. aureus, 
which was able to re-infect new osteoblasts (Ellington 
et al., 2003), while in this study the viability of infected 
osteoblasts decreased slightly over time (84.6 ±6.7 % at 
post-infection day 1 vs. 77.4 ±0.6 % at day 7). S. aureus 
can also internalize and perhaps even replicate within 
bovine mammary epithelial cells, both in cell lines and 
in primary culture (Almeida et al., 1996; Bayles et al., 
1998). In vivo, intra-cellular S. aureus and S. epidermidis 
were found, in a few limited cases, in animals and patients. 
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In animal studies, S. epidermidis was found to persist in 
macrophages in mice and may play an important role in the 
pathogenesis of biomaterial-associated infection (Boelens 
et al., 2000; Broekhuizen et al., 2008). S. aureus was found 
to be able to internalize and survive in osteoblasts of chick 
embryos (Reilly et al., 2000) and in bovine alveolar cells 
isolated from milk of infected cows (Hébert et al., 2000). 
More interestingly, S. aureus (~1×106 CFU) surviving 
in neutrophils was able to establish infection after being 
injected intraperitoneally into naïve mice (Gresham et 
al., 2000). In human studies, intra-cellular S. aureus was 
found inside epithelium, glandular and myofibroblastic 
cells in intranasal biopsy specimens obtained, during 
infection symptom-free periods, from three patients with 
recurrent rhinosinusitis (Clement et al., 2005). Molecular 
typing proved the clonal relationship of the patient-
specific Staphylococci. Intra-cellular S. aureus was also 
found in surgical bone specimens from a patient who had 
chronic, recurrent bone infection (Bosse et al., 2005). 
The intra-cellular S. aureus appeared to be sequestered 
and protected from the host immune system within the 
osteoblast or osteocyte cytoplasm for years (Bosse et al., 
2005). In another case, intra-cellular S. aureus was cultured 
from five patients with persistent recurring osteomyelitis 
infections (Proctor et al., 1995). Alarmingly, some of 
the intra-cellular S. aureus were small-colony variants 
which were nonhemolytic and nonpigmented, grew very 
slowly on routine culture media, and were resistant to 
aminoglycosides under routine conditions.
 Therefore, there is some in vitro and in vivo evidence 
supporting the potential role of intra-cellular S. aureus in 
Staphylococci pathogenesis. The results presented here 
are important because they demonstrate that intra-cellular 
S. aureus can induce infection in vivo. Bacteria (e.g. S. 
aureus) could internalize and survive within host cells (e.g. 
osteoblasts) and, after “hiding” for some time period (could 
be up to years, see Bosse et al., 2005), these quiescent 
bacteria could escape from the infected host cells into 
the surrounding tissue and could be sufficient to initiate a 
recurrence of symptomatic infection. It is also possible that, 
upon escaping from the host cells, bacteria may internalize 
into other host cells (e.g. neutrophils, macrophages). All of 
these may help to understand the pathogenesis of infections 
like periprosthetic joint infection, with which high infection 
recurrence (8-11 %) has been reported (Lieberman et al., 
1994; Takahira et al., 2003) even after extensive antibiotic 
treatments during the two-stage exchange arthroplasty 
(gold standard in North America).
 Taken together, our findings present direct in vivo 
evidence that intra-cellular S. aureus could induce bone 
infections and could be responsible for chronic and 
recurrent infections. These findings also suggested that as 
low as 102 CFU of intra-cellular S. aureus could induce 
severe bone infections in open fractures. These findings 
may greatly advance our understanding of the pathogenesis 
of bone infections, especially for chronic and recurrent 
infections. The induction of bone infections by intra-
cellular S. aureus was studied in this work; however, the 
findings are expected to be applicable to other infections/
diseases and intra-cellular pathogens.
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Discussion with Reviewer
Reviewer I: The authors state that 102 and 106 S. aureus 
caused infection in earlier studies when added as free 
bacteria, and therefore selected 20 CFU as the number of 
CFU to administer as free bacteria control in this study. 
The lowest dose of bacteria administered as internalized 
bacteria in osteoblasts, however, was 100 CFU. It might 
have been more systematic to use the same number of 
bacteria as free inoculum and as internalized inoculum, i.e. 
also have a group infected with only 20 CFU internalized. 
Can the authors please comment on this?
Authors: This reviewer makes a good point. From our 
previous studies, we knew that 102 CFU/0.1 mL of extra-
cellular S. aureus induced infection in our open fracture 
rat model (Li et al., 2009; Li et al., 2010; Boyce et al., 
2012). We hoped that 20-50 CFU/0.1 mL would not induce 
infection and the inclusion of such a group of low extra-
cellular S. aureus would help us evaluate the potential 
role of intra-cellular S. aureus in inducing infection by 
comparing Group III with Group VI in this study. It would 
be another interesting study to have a group infected with 
only 20 CFU of intra-cellular S. aureus to determine if 
such a group will result in infection as well. If such a group 
would result in infection while 20 CFU of extra-cellular 
S. aureus did not lead to infection as found in this study, it 
would mean that intra-cellular pathogens are more virulent.
